Prostate derived Ets transcription factor and carcinoembryonic antigen related cell adhesion molecule 6 constitute a highly active oncogenic axis in breast cancer

Oncotarget

Volumn 4, Issue 4, 2013, Pages 610-621

  Mukhopadhyay, Alka ^a   Khoury, Thaer ^a   Stein, Leighton ^a   Shrikant, Protul ^a   Sood, Ashwani K ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

CEACAM6; Elevated co expression; Novel targets in breast cancer; PDEF; PDEF CEACAM6 oncogenic axis; SPDEF; Tumor cell survival

Indexed keywords

CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 6; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; MESSENGER RNA; PSORIASIN; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR ETS; V SET DOMAIN CONTAINING T CELL ACTIVATION INHIBITOR 1;

ARTICLE; B7 H4 GENE; BREAST CANCER; CEACAM6 GENE; CELL STRAIN MCF 7; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; PROTEIN EXPRESSION; S100A7 GENE; TRIPLE NEGATIVE BREAST CANCER;

EID: 84879137568     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.934     Document Type: Article

References (33)

1. Early Breast Cancer Trialists' Collaborative, G. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005; 365 (9472):1687-1717.
2. Dawood, S., K. Broglio, Buzdar, A. U., Hortobagyi, G. N., Giordano, S. H. Prognosis of women with metastatic breast cancer by HER2 status and trastuzumab treatment: an institutional-based review. J Clin Oncol. 2010; 28(1):92-98.
3. Osborne, C. K. and R. Schiff. Mechanisms of endocrine resistance in breast cancer. Annu Rev Med. 2011; 62:233-247.
4. Johnston, S. R. New strategies in estrogen receptor-positive breast cancer. Clin Cancer Res. 2010; 16(7):1979-1987.
5. Pohlmann, P. R., I. A. Mayer, Mernaugh, R. Resistance to Trastuzumab in Breast Cancer. Clin Cancer Res. 2009; 15(24):7479-7491.
6. Wilson, T. R., J. Fridlyand, Yan, Y., Penuel, E., Burton, L., Chan, E., Peng, J., Lin, E., Wang, Y., Sosman, J., Ribas, A., Li, J., Moffat, J., Sutherlin, D. P., Koeppen, H., Merchant, M., et al. Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors. Nature. 2012; 487(7408):505-509.
7. Wasylyk, B., J. Hagman, Gutierrez-Hartmann, A. Ets transcription factors: nuclear effectors of the Ras-MAPkinase signaling pathway. Trends Biochem Sci. 1998; 23(6):213-216.
8. Sharrocks, A. D. The ETS-domain transcription factor family. Nat Rev Mol Cell Biol. 2001; 2(11):827-837.
9. Dittmer, J., Nordheim, A. Ets transcription factors and human disease. Biochim Biophys Acta. 1998; 1377(2): F1-11.
10. Gilliland, D. G. The diverse role of the ETS family of transcription factors in cancer. Clin Cancer Res. 2001; 7(3):451-453.
11. Tomlins, S. A., B. Laxman, Dhanasekaran, S. M., Helgeson, B. E., Cao, X., Morris, D. S., Menon, A., Jing, X., Cao, Q., Han, B., Yu, J., Wang, L., Montie, J. E., Rubin, M. A., Pienta, K. J., Roulston, D., et al. Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer. Nature. 2007; 448(7153):595-599.
12. Oettgen, P., E. Finger, Sun, Z., Akbarali, Y., Thamrongsak, U., Boltax, J., Grall, F., Dube, A., Weiss, A., Brown, L., Quinn, G., Kas, K., Endress, G., Kunsch, C., Libermann, T. A. PDEF, a novel prostate epithelium-specific ets transcription factor, interacts with the androgen receptor and activates prostate-specific antigen gene expression. J Biol Chem. 2000; 275(2):1216-1225.
13. Ghadersohi, A., Sood, A.K. Prostate epithelium-derived Ets transcription factor mRNA is overexpressed in human breast tumors and is a candidate breast tumor marker and a breast tumor antigen. Clin Cancer Res. 2001; 7(9):2731-2738.
14. Turcotte, S., M. A. Forget, Beauseigle, D., Nassif, E., Lapointe, R. Prostate-derived Ets transcription factor overexpression is associated with nodal metastasis and hormone receptor positivity in invasive breast cancer. Neoplasia. 2007; 9(10):788-796.
15. Sood, A. K., R. Saxena, Groth, J., Desouki, M.M., Cheewakriangkrai, C., Rodabaugh, K. J., Kasyapa, C. S., Geradts, J. "Expression characteristics of prostate-derived Ets factor support a role in breast and prostate cancer progression. Hum Pathol. 2007; 38(11):1628-1638.
16. Gunawardane, R. N., D. C. Sgroi, Wrobel, C. N.,Koh, E., Daley, G. Q. Brugge, J. S. Novel role for PDEF in epithelial cell migration and invasion. Cancer Res. 2005; 65(24):11572-11580.
17. Mitas, M., K. Mikhitarian, Hoover, L., Lockett, M. A., Kelley, L., Hill, A., Gillanders, W. E., Cole, D. J. Prostate-Specific Ets (PSE) factor: a novel marker for detection of metastatic breast cancer in axillary lymph nodes. Br J Cancer. 2002; 86(6):899-904.
18. Sood, A. K., J. Wang, Mhawech-Fauceglia, P., Jana, B., Liang, P., Geradts, J. Sam-pointed domain containing Ets transcription factor in luminal breast cancer pathogenesis. Cancer Epidemiol Biomarkers Prev. 2009; 18(6):1899-1903.
19. Chan, C. H. and C. P. Stanners. Recent advances in the tumour biology of the GPI-anchored carcinoembryonic antigen family members CEACAM5 and CEACAM6. Curr Oncol. 2007; 14(2):70-73.
20. Oikawa, S., C. Inuzuka, Kuroki, M., Matsuoka, Y., Kosaki, G., Nakazato, H. Cell adhesion activity of non-specific cross-reacting antigen (NCA) and carcinoembryonic antigen (CEA) expressed on CHO cell surface: homophilic and heterophilic adhesion. Biochem Biophys Res Commun. 1989; 164(1):39-45.
21. Zhou, H., A. Fuks, Stanners, C. P. Specificity of intercellular adhesion mediated by various members of the immunoglobulin supergene family. Cell Growth Differ. 1990; 1(5):209-215.
22. Chan, C. H., P. Camacho-Leal, Stanners, C. P. Colorectal hyperplasia and dysplasia due to human carcinoembryonic antigen (CEA) family member expression in transgenic mice. PLoS One. 2007; 2(12):e1353.
23. Ordonez, C., R. A. Screaton, Ilantzis, C., Stanners, C. P. Human carcinoembryonic antigen functions as a general inhibitor of anoikis. Cancer Res. 2000; 60(13):3419-3424.
24. Duxbury, M. S., H. Ito, Zinner, M. J., Ashley, S. W., Whang, E. E. CEACAM6 gene silencing impairs anoikis resistance and in vivo metastatic ability of pancreatic adenocarcinoma cells. Oncogene. 2004; 23(2):465-473.
25. Tringler, B., S. Zhuo, et al. B7-h4 is highly expressed in ductal and lobular breast cancer. Clin Cancer Res. 2005; 11(5):1842-1848.
26. Emberley, E. D., L. C. Murphy, Watson, P. H. S100A7 and the progression of breast cancer. Breast Cancer Res. 2004; 6(4):153-159.
27. Tavakkol, A., C. C. Zouboulis, Duell, E. A., Voorhees, J. J., A retinoic acid-inducible skin-specific gene (RIS-1/psoriasin): molecular cloning and analysis of gene expression in human skin in vivo and cultured skin cells in vitro. Mol Biol Rep. 1994; 20(2):75-83.
28. Blumenthal, R. D., E. Leon, Hansen, H. J., Goldenberg, D. M. Expression patterns of CEACAM5 and CEACAM6 in primary and metastatic cancers. BMC Cancer. 2007; 7:2.
29. Scholzel, S., W. Zimmermann, Schwarzkopf, G., Grunert, F., Rogaczewski, B., Thompson, J. Carcinoembryonic antigen family members CEACAM6 and CEACAM7 are differentially expressed in normal tissues and oppositely deregulated in hyperplastic colorectal polyps and early adenomas. Am J Pathol. 2000; 156(2):595-605.
30. Turner, D. P., V. J. Findlay, Kirven, A. D., Moussa, O., Watson, D. K. Global gene expression analysis identifies PDEF transcriptional networks regulating cell migration during cancer progression. Mol Biol Cell. 2008; 19(9):3745-3757.
31. Perou, C. M., T. Sorlie, Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., Fluge, O., Pergamenschikov, A., Williams, C., Zhu, S. X., Lonning, P. E., Borresen-Dale, A. L., Brown, P. O., Botstein, D. Molecular portraits of human breast tumours. Nature. 2000; 406(6797):747-752.
32. Cidado, J., J. A. Beaver, Park, B. H. Needles in a haystack: finding recurrent genomic changes in breast cancer. Breast Cancer Res. 2013; 14(1):304-305.
33. Polyak, K. and O. Metzger Filho. SnapShot: breast cancer. Cancer Cell. 2012;22(4):562-562.e1.